ASTH · Astrana Health, Inc.
$40.81
+3.02 (+7.99%)
At close · Aug 14
Market Cap
$2.27B
Shares
55.74M
Astrana Health, Inc. Earnings Call Transcripts
Every quarterly earnings call for Astrana Health, Inc. (ASTH) — the full transcript with speaker labels, the audio replay, AI call highlights and a management-tone score, plus the matching 8-K earnings release and the quarter's 10-Q or 10-K. Investor days and conferences appear here too.
Revenue & result across quarters
Revenue Net income YoY up YoY down artefacts
▲39.6%
$317.00M
$23.18M
'22 Q3
22-11-04
▲50.8%
$294.21M
−$3.73M
'22 Q4
23-02-23
▲28.1%
$337.24M
$13.13M
'23 Q1
23-05-08
▲29.1%
$348.21M
$13.17M
'23 Q2
23-08-07
▲9.8%
$348.17M
$22.06M
'23 Q3
23-11-07
▲20%
$353.04M
$12.36M
'23 Q4
24-02-27
▲19.9%
$404.36M
$14.84M
'24 Q1
24-05-07
▲39.6%
$486.26M
$19.17M
'24 Q2
24-08-07
▲37.5%
$478.71M
$16.09M
'24 Q3
24-11-07
▲88.4%
$665.21M
−$6.95M
'24 Q4
25-02-27
▲53.4%
$620.39M
$6.69M
'25 Q1
25-05-08
▲34.7%
$654.81M
$9.42M
'25 Q2
25-07-02
▲99.7%
$956.05M
$373,000
'25 Q3
25-11-06
▲42.9%
$950.52M
$6.00M
'25 Q4
26-03-02
▲55.6%
$965.10M
$14.44M
'26 Q1
26-05-07
LATEST
▲48.5%
$972.52M
$19.74M
'26 Q2
26-08-06
Earnings call
FY26 · Q2
2026-08-06
Second Quarter 2026 Financial Results Conference Call
Positive tone
Geographic expansion
Guidance and outlook
Medicaid / Medi-Cal rebalancing
Revenue
$972.52M
▲ 48.5% YoY Diluted EPS
$0.40
▲ 110.5% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Conference
Investor event
2026-05-12
Bank of America Global Healthcare Conference 2026
No reported result — non-financial event
Audio
Transcript
Slides
Earnings call
FY26 · Q1
2026-05-07
Astrana Health, Inc. Q1 FY2026 Earnings Call
Confident tone
Financial performance and deleveraging
Medicaid / ACA membership and adverse selection
Medical cost trend and underwriting
Revenue
$965.10M
▲ 55.6% YoY Diluted EPS
$0.29
▲ 107.1% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Conference
Investor event
2026-03-11
Barclays 28th Annual Global Healthcare Conference
No reported result — non-financial event
Audio
Transcript
Slides
Earnings call
FY25 · Q4
2026-03-02
Astrana Health, Inc. Q4 FY2025 Earnings Call
Confident tone
Prospect acquisition integration and synergies
Medicaid and D-SNP/HICS headwinds and guidance assumptions
Membership growth and geographic diversification
Revenue
$950.52M*
▲ 42.9% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Conference
Investor event
2026-01-12
J.P. Morgan 2026 Healthcare Conference
No reported result — non-financial event
Audio
Transcript
Slides
Earnings call
FY25 · Q3
2025-11-06
Astrana Health, Inc. Q3 FY2025 Earnings Call
Confident tone
2025 Guidance & 2026 Outlook
Risk Progression & Full-Risk Transition
Strategic Partnerships & Pipeline
Revenue
$956.05M
▲ 99.7% YoY Diluted EPS
$0.01
▼ 97% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q2
2025-07-02
Astrana Health, Inc. Q2 FY2025 Earnings Call
Confident tone
Prospect Acquisition & Integration
Guidance and Financial Results
Medicaid Policy Headwinds
Revenue
$654.81M
▲ 34.7% YoY Diluted EPS
$0.19
▼ 52.5% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q1
2025-05-08
Astrana Health, Inc. Q1 FY2025 Earnings Call
Confident tone
CHS Acquisition Integration
Prospect Health Acquisition
Revenue and Earnings Growth
Revenue
$620.39M
▲ 53.4% YoY Diluted EPS
$0.14
▼ 54.8% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q4
2025-02-27
Astrana Health, Inc. Q4 FY2024 Earnings Call
Revenue
$665.21M*
▲ 88.4% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY24 · Q3
2024-11-07
Astrana Health, Inc. Q3 FY2024 Earnings Call
Positive tone
Revenue and EBITDA Growth
Collaborative Health Systems Acquisition
Risk Mix and Full Risk Transition
Revenue
$478.71M
▲ 37.5% YoY Diluted EPS
$0.33
▼ 29.8% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q2
2024-08-07
Astrana Health, Inc. Q2 FY2024 Earnings Call
Confident tone
CHS Acquisition from Centene
Revenue and Adjusted EBITDA Growth
Full Risk / Value-Based Care Migration
Revenue
$486.26M
▲ 39.6% YoY Diluted EPS
$0.40
▲ 42.9% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q1
2024-05-07
Astrana Health, Inc. Q1 FY2024 Earnings Call
Confident tone
Value-based care and risk arrangements
ACO REACH and MSSP programs
Strategic acquisitions
Revenue
$404.36M
▲ 19.9% YoY Diluted EPS
$0.31
▲ 10.7% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q4
2024-02-27
Astrana Health, Inc. Q4 FY2023 Earnings Call
Confident tone
Revenue and EBITDA growth
BASS Medical Group partnership
Segment growth mix (Partners, Enablement, Delivery)
Revenue
$353.04M*
▲ 20% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY23 · Q3
2023-11-07
Astrana Health, Inc. Q3 FY2023 Earnings Call
Revenue
$348.17M
▲ 9.8% YoY Diluted EPS
$0.47
▼ 6% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q2
2023-08-07
Astrana Health, Inc. Q2 FY2023 Earnings Call
Revenue
$348.21M
▲ 29.1% YoY Diluted EPS
$0.28
▲ 7.7% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q1
2023-05-08
Astrana Health, Inc. Q1 FY2023 Earnings Call
Revenue
$337.24M
▲ 28.1% YoY Diluted EPS
$0.28
▼ 6.7% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q4
2023-02-23
Astrana Health, Inc. Q4 FY2022 Earnings Call
Revenue
$294.21M
▲ 50.8% YoY Diluted EPS
$-0.08
▼ 129.6% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY22 · Q3
2022-11-04
Astrana Health, Inc. Q3 FY2022 Earnings Call
Revenue
$317.00M
▲ 39.6% YoY Diluted EPS
$0.50
▼ 32.4% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q2
2022-08-04
Astrana Health, Inc. Q2 FY2022 Earnings Call
Revenue
$269.70M
▲ 53.6% YoY Diluted EPS
$0.26
▲ 18.2% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q1
2022-05-05
Astrana Health, Inc. Q1 FY2022 Earnings Call
Revenue
$263.26M
▲ 49.5% YoY Diluted EPS
$0.30
▲ 7.1% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q4
2022-02-24
Astrana Health, Inc. Q4 FY2021 Earnings Call
Revenue
$195.10M
▲ 10.4% YoY Diluted EPS
$0.27
▲ 3.8% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY21 · Q3
2021-11-04
Astrana Health, Inc. Q3 FY2021 Earnings Call
Revenue
$227.12M
▲ 26.1% YoY Diluted EPS
$0.74
▲ 64.4% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q2
2021-08-05
Astrana Health, Inc. Q2 FY2021 Earnings Call
Revenue
$175.64M
▲ 6.3% YoY Diluted EPS
$0.22
▲ 15.8% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q1
2021-05-05
Astrana Health, Inc. Q1 FY2021 Earnings Call
Revenue
$176.06M
▲ 6.6% YoY Diluted EPS
$0.28
▲ 154.5% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q4
2021-03-10
Astrana Health, Inc. Q4 FY2020 Earnings Call
Revenue
$176.78M
▼ 1.1% YoY Diluted EPS
$0.26
▲ 44.4% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Showing 1–26 of 26 earnings calls
Key facts
CIK
1083446
CUSIP
03763A207
13F (30d)
196 filings
195 filers
Visit website
Investor relations